Min Ma
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Natural Compounds in Disease Treatment
Papers in
-
- Cancer-related molecular mechanisms research 6
- MicroRNA in disease regulation 5
- Co-authors
- Zhengzhi Wu (12 shared papers)Changwei Lin (7 shared papers)Qiang Zeng (6 shared papers)Dongmei Gao (7 shared papers)Jiefeng Cui (7 shared papers)Rui Zhang (7 shared papers)Fei Long (5 shared papers)Guijuan Zhang (12 shared papers)
- Journals
- Scientific Reports (6 papers)Evidence-based Complementary and Alternative Medicine (5 papers)BMC Cancer (3 papers)Nature Communications (2 papers)International Journal of Biological Macromolecules (2 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Min Ma
112 papers receiving 2.4k citations
Peers
Comparison fields: 5 of 104
- Cancer Research 268
- Complementary and alternative medicine 184
- Hepatology 114
- Molecular Biology 682
- Drug Discovery 3
Countries citing papers authored by Min Ma
This map shows the geographic impact of Min Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Min Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Min Ma more than expected).
Fields of papers citing papers by Min Ma
This network shows the impact of papers produced by Min Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Min Ma. The network helps show where Min Ma may publish in the future.
Co-authors
The 25 scholars most cited alongside Min Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 118 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 137 | |
| 2 | 2017 | 81 | |
| 3 | 2019 | 80 | |
| 4 | 2018 | 73 | |
| 5 | 2020 | 73 | |
| 6 | 2018 | 60 | |
| 7 | 2022 | 59 | |
| 8 | 2010 | 56 | |
| 9 | 2019 | 51 | |
| 10 | 2019 | 49 | |
| 11 | 2019 | 48 | |
| 12 | 2017 | 45 | |
| 13 | 2017 | 44 | |
| 14 | 2020 | 44 | |
| 15 | 2019 | 42 | |
| 16 | 2016 | 40 | |
| 17 | 2018 | 40 | |
| 18 | 2017 | 39 | |
| 19 | 2018 | 38 | |
| 20 | 2020 | 37 |
About Min Ma
Min Ma is a scholar working on Cancer Research, Complementary and alternative medicine, Molecular Biology, Plant Science and Hepatology, having authored 118 papers that have together received 2.5k indexed citations. Recurring topics across this work include Postharvest Quality and Shelf Life Management (7 papers), Cancer-related molecular mechanisms research (6 papers), Hepatocellular Carcinoma Treatment and Prognosis (5 papers), MicroRNA in disease regulation (5 papers), Gastric Cancer Management and Outcomes (4 papers), Microbial Natural Products and Biosynthesis (4 papers), Extracellular vesicles in disease (4 papers) and Plant Molecular Biology Research (4 papers). The work is most often cited by research in Cancer Research (268 citations), Complementary and alternative medicine (184 citations), Hepatology (114 citations), Molecular Biology (682 citations) and Drug Discovery (3 citations). Min Ma has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Zhengzhi Wu, Changwei Lin, Qiang Zeng, Dongmei Gao, Jiefeng Cui, Rui Zhang, Fei Long, Guijuan Zhang, Xiaorong Li and Xuefeng Jiang. Their work appears in journals such as Scientific Reports, Evidence-based Complementary and Alternative Medicine, BMC Cancer, Nature Communications and International Journal of Biological Macromolecules.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.